The realisation that human, animal, viral and bacterial genomes all contain over-representation of higher-order quadruplex structures in regulatory and other pharmacologically-useful regions, has led to a large number of studies aimed at exploiting this findings for therapeutic and diagnostic purposes. Quadruplex-binding small molecules are starting to be evaluated in human clinical trials.
Provides the authority and expertise of leading contributors from an international board of authorsPresents the latest release in the Annual Reports in Medicinal Chemistry series
Gör som tusentals andra bokälskare
Prenumerera på vårt nyhetsbrev för att få fantastiska erbjudanden och inspiration för din nästa läsning.
Genom att registrera dig accepterar du vår personuppgiftspolicy.Du kan alltid välja att avsluta prenumerationen.
